Harnessing In Vivo Disease Models to Turbocharge Treatment Success
Time: 3:30 pm
day: Conference Day One PM
Details:
- Utilizing mouse models to uncover the mechanism of action for Treg cell therapy in autoimmune and autoinflammatory diseases
- Identifying the properties of an ideal preclinical, in vivo model to provide insights for future model development
- Prioritizing translational relevance of key preclinical biomarkers in murine models of inflammatory diseases
